About Aperta Biosciences
Aperta Biosciences is a company based in Austin (United States) founded in 2017 by Carlos Santos. It operates as a B2B. Aperta Biosciences offers products and services including APT-001.
- Headquarter Austin, United States
- Founders Carlos Santos
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Aperta Biosciences, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aperta Biosciences
Aperta Biosciences offers a comprehensive portfolio of products and services, including APT-001. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Ophthalmic suspension targeting demodicosis to treat blepharitis effectively
Funding Insights of Aperta Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Aperta Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aperta Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aperta Biosciences Comparisons
Competitors of Aperta Biosciences
Frequently Asked Questions about Aperta Biosciences
When was Aperta Biosciences founded?
Aperta Biosciences was founded in 2017.
Where is Aperta Biosciences located?
Aperta Biosciences is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Who is the current CEO of Aperta Biosciences?
Carlos Santos is the current CEO of Aperta Biosciences. They have also founded this company.
What does Aperta Biosciences do?
Aperta Biosciences is a biopharma company that focuses on creating new therapeutics for ocular surface diseases, including blepharitis, ocular rosacea, and dry eye. It targets underlying causes like demodicosis using reformulated drugs such as APT-001. Led by experienced professionals in ophthalmology, the company operates from Austin, Texas, aiming to address inflammation and prevent vision complications through research and development.
What products or services does Aperta Biosciences offer?
Aperta Biosciences offers APT-001.